Inventaire - teman dan komunitas anda adalah perpustakaan terbaik

Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis.

pengarang

Mark MacEachern

diterbitkan dalam: Osteoporosis International

tanggal publikasi: 2017-08-02

bahasa: Inggris

subyek utama: Osteoporosis, Tinjauan sistematis

Cites articles 63

Date

Judul

Pengarang

2017-02-07

Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures

Nicholas C Harvey, Paul J Mitchell, Cyrus Cooper, Bess Dawson-Hughes
2017-01-26

Effect of Teriparatide or Risedronate in Elderly Patients With a Recent Pertrochanteric Hip Fracture: Final Results of a 78-Week Randomized Clinical Trial

Søren Overgaard, Kyriakos A Papavasiliou, Francisco Marín
2015-06-01

Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis
2015-10-01

Anti-Osteoporotic Therapy After Fragility Fracture Lowers Rate of Subsequent Fracture: Analysis of a Large Population Sample.

Harpreet S Bawa
2015-12-09

Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate
2014-04-01

Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
2013-10-11

Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EF

Cyrus Cooper
2013-11-09

Once-weekly teriparatide reduces the risk of vertebral fracture in patients with various fracture risks: subgroup analysis of the Teriparatide Once-Weekly Efficacy Research (TOWER) trial
2013-02-19

A health economic analysis of osteoporotic fractures: who carries the burden?

Louise Hansen, Karin Dam Petersen
2013-03-01

Best practices in secondary fracture prevention: fracture liaison services
2013-04-16

Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle

Cyrus Cooper
2012-05-29

Time to onset of efficacy in fracture reduction with current anti-osteoporosis treatments

Michelle Lai
2012-07-26

Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention

Paul J Mitchell, John A Eisman
2011-05-24

Coordinator-based systems for secondary prevention in fragility fracture patients

Dorcas E Beaton, Joanna E M Sale, Earl Bogoch
2011-09-01

Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women
2010-01-01

Benefits and risks of raloxifene by vertebral fracture status
2010-02-01

Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures

Thomas A Einhorn
2010-11-04

Oral bisphosphonates are associated with reduced mortality after hip fracture
2009-08-20

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

Michael McClung, Ian Reid, Silvano Adami, Richard Eastell
2009-10

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Douglas G. Altman, David Moher, Jennifer Tetzlaff, Alessandro Liberati
2008-09-01

Bisphosphonates: mechanism of action and role in clinical practice

Sundeep Khosla
2008-12-01

Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial.
2008-05-01

Improving evaluation and treatment for osteoporosis following distal radial fractures. A prospective randomized intervention

Mary L. Bouxsein
2008-01-23

Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women

Peter Tugwell, Beverley Shea, Vivian Welch, George Wells, Ann Cranney, Doug Coyle
2008-01-23

Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women

Peter Tugwell, Beverley Shea, Doug Coyle, Vivian Welch, George Wells, Ann Cranney
2008-01-23

Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women

Doug Coyle
2008-09-01

Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations

Anna N. A. Tosteson
2007-09-17

Zoledronic acid and clinical fractures and mortality after hip fracture

Jay Magaziner
2007-03-01

Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

Bess Dawson-Hughes, Anna N. A. Tosteson
2007-05-01

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

Ian Reid, Jane A. Cauley, Dennis M Black, Steven R Cummings, Richard Eastell, Steven Boonen, Felicia Cosman, Ping-Chung Leung, Zulema Man, Trisha F Hue, Erik F Eriksen, HORIZON Pivotal Fracture Trial
2007-01-01

The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature
2007-12-17

Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis

Sydne J Newberry, Margaret A Maglione, Marika Suttorp Booth

Artikel - wd:Q51832370

Selamat datang di Inventaire

perpustakaan teman-teman dan komunitas anda

pelajari lebih lanjut